Bromocriptine Mesylate Protects against Status Epilepticus and Temporal Lobe Epilepsy: Neurobehavioral, Histopathological and Neurochemical Evidences
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 6, Issue 4
Abstract
Background: Dopamine (DA) plays a major role in the control of epileptic seizures arising in the limbic system, through D1/D2 receptor-mediated signaling. Objective: The study was intended to investigate whether bromocriptine mesylate (BRC), a dopamine (D2) receptor agonist, has an anti-seizure property, attenuates oxidative stress and neuronal morphological alterations against pilocarpine induced status epilepticus (SE) in mice, using sodium valproate (SVP) as comparator AED. Materials and Methods: SVP (300 mg/kg) and BRC (6 &10 mg/kg) were administered orally once daily for a period of 4 weeks followed by pilocarpine (300 mg/kg, i.p) to induce SE. The convulsions were monitored for 2 hrs post pilocarpine injection. At 2 hrs post pilocarpine injection hippocampal malondialdehyde, glutathione reduced, glutathione peroxidase, glutathione reductase and catalase activities were measured. While hippocampal histopathological assessment of neuronal injury was performed 24 hrs post pilocarpine injection. Results: We report that SVP (300 mg/kg) and BRC (6 &10 mg/kg) were able to reduce seizure severity score (P<0.001, P<0.01, P<0.05), attenuate oxidative damage in lipids and proteins, restore depletion in hippocampal glutathione reduced, glutathione peroxidase and glutathione reductase activities compared to toxic/pilocarpine control. Contrary catalase levels were strengthened as like pilocarpine control. In addition SVP (300 mg/kg) and BRC (6 & 10 mg/kg) protected against degeneration in hippocampal CA1, CA2, CA3 & DG regions (P<0.001, P<0.01, P<0.05) compared to pilocarpine control. Conclusions: The present study highlights the prominent dysregulation of dopaminergic system in seizures and perspectives for the development of novel therapeutic approaches acompassing dopaminergic drugs in amelioration of epileptic seizures especially status-epilepticus and temporal lobe epilepsy.
Authors and Affiliations
Faheem Hyder Pottoo, Nahida Tabassum, Mohammad Maqbool Darzi
Keywords
Related Articles
- EP ID EP241813
- DOI 10.9734/INDJ/2016/24401
- Views 129
- Downloads 0
The Characteristics of Cognitive Functions in Patients with Acute Disseminated Encephalomyelitis
Introduction: The clinical picture of acute disseminated encephalomyelitis is characterized not only by a variety of neurological signs, but also by disorders of higher cortical functions. Disorders of higher cognitive f...
Transition of Service Users from Child to Adult Mental Health Clinic in Lagos Nigeria
Adolescence is a potentially stressful period characterised by various developmental changes. Disruption in provision and utilisation of mental health services during the transition from adolescence to adulthood has dire...
Behavioral and Psychological Symptoms of Dementia in Nigerian Hospital Patients: Prevalence, Correlates and Caregiver Burden
Aims: This study was aimed at measuring the prevalence and impact of Behavioral and Psychological Symptoms of Dementia (BPSD) of elderly hospital attendees in Lagos Nigeria; and determining socio-cultural factors associa...
A Facility-based Assessment of Internalized Stigma among Patients with Severe Mental Illnesses in Maiduguri, North-Eastern Nigeria
Introduction: Public stigmatization of mental illnesses might lead to the internalization of the stigma by persons with mental illness (PWMIs) which might also lead to erosion of self-esteem and negative consequences on...
Prolonged Use of Benzodiazepines for Sleep Disturbances in the Elderly: Quality of Sleep and Related Comorbidities
Introduction: Insomnia is frequently found in older people, and may be symptomatic of underlying comorbid conditions. The use of drug therapy for the symptomatic relief of insomnia is widespread, with the most common cla...